Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis
Folia Biologica · 2023 · 69 (4) · 116-126
DOI: 10.14712/fb2023069040116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Biologica, online erschienen am 27.02.2024. Verfasst von Anton Tkachenko und 1 weiteren Autor:innen. Beteiligte Einrichtung: BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic. Hauptthemen laut MEDLINE: Eryptosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Univerzita Karlova v Praze.
Abstract (Originalsprache)
Overall, reactive oxygen species (ROS) signalling significantly contributes to initiation and modulation of multiple regulated cell death (RCD) pathways. Lately, more information has become available about RCD modalities of erythrocytes, including the role of ROS. ROS accumulation has therefore been increasingly recognized as a critical factor involved in eryptosis (apoptosis of erythrocytes) and erythronecroptosis (necroptosis of erythrocytes). Eryptosis is a Ca 2+ -dependent apoptosis-like RCD of erythrocytes that occurs in response to oxidative stress, hyperosmolarity, ATP depletion, and a wide range of xenobiotics. Moreover, eryptosis seems to be involved in the pathogenesis of multiple human diseases and pathological processes. Several studies have reported that erythrocytes can also undergo necroptosis, a lytic RIPK1/RIPK3/MLKL-mediated RCD. As an example, erythronecroptosis can occur in response to CD59-specific pore-forming toxins. We have systematically summarized available studies regarding the involvement of ROS and oxidative stress in these two distinct RCDs of erythrocytes. We have focused specifically on cellular signalling pathways involved in ROS-mediated cell death decisions in erythrocytes. Furthermore, we have summarized dysregulation of related erythrocytic antioxidant defence systems. The general concept of the ROS role in eryptotic and necroptotic cell death pathways in erythrocytes seems to be established. However, further studies are required to uncover the complex role of ROS in the crosstalk and interplay between the survival and RCDs of erythrocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic.
- 1st Department of Medicine - Department of Haematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. ondrej.havranek@lf1.cuni.cz.
- BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic. ondrej.havranek@lf1.cuni.cz.
Förderung
- Univerzita Karlova v Praze
Zitieren
APA
Tkachenko, A., & Havránek, O. (2023). Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis. Folia Biologica, 69(4), 116-126. https://doi.org/10.14712/fb2023069040116
Vancouver
Tkachenko A, Havránek O. Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis. Folia Biologica. 2023;69(4):116-126. doi:10.14712/fb2023069040116
BibTeX
@article{Tkachenko2023,
author = {Tkachenko, Anton and Havránek, Ondřej},
title = {Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis},
journal = {Folia Biologica},
year = {2023},
volume = {69},
number = {4},
pages = {116--126},
doi = {10.14712/fb2023069040116}
}
EUVIMED